Michael P. Stehn
Corporate Officer/Principal bei Parenteral Drug Association
Profil
Michael P.
Stehn is a Member of the Parenteral Drug Association.
He was previously the Director of Quality Assurance & Regulatory Compliance at The Rugby Group, Inc. and the Senior Vice President of Operations at Akorn, Inc. from 1990 to 2020.
He obtained an undergraduate degree from Fairleigh Dickinson University.
Currently, Mr. Stehn holds a job at Parenteral Drug Association.
Aktive Positionen von Michael P. Stehn
| Unternehmen | Position | Beginn |
|---|---|---|
| Parenteral Drug Association | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael P. Stehn
| Unternehmen | Position | Ende |
|---|---|---|
| AKORN, INC. | Geschäftsführer | 05.09.2012 |
The Rugby Group, Inc.
 The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million. | Corporate Officer/Principal | - |
Ausbildung von Michael P. Stehn
| Fairleigh Dickinson University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
The Rugby Group, Inc.
The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million. | Health Technology |
| Parenteral Drug Association |
